PL3621589T3 - Sposób wytwarzania preparatu suchego proszku obejmującego środek antycholinergiczny, kortykosteroid i środek beta-adrenergiczny - Google Patents
Sposób wytwarzania preparatu suchego proszku obejmującego środek antycholinergiczny, kortykosteroid i środek beta-adrenergicznyInfo
- Publication number
- PL3621589T3 PL3621589T3 PL18725151T PL18725151T PL3621589T3 PL 3621589 T3 PL3621589 T3 PL 3621589T3 PL 18725151 T PL18725151 T PL 18725151T PL 18725151 T PL18725151 T PL 18725151T PL 3621589 T3 PL3621589 T3 PL 3621589T3
- Authority
- PL
- Poland
- Prior art keywords
- anticholinergic
- corticosteroid
- adrenergic
- beta
- preparing
- Prior art date
Links
- 230000001078 anti-cholinergic effect Effects 0.000 title 1
- 239000003246 corticosteroid Substances 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000000843 powder Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17170632 | 2017-05-11 | ||
| EP18725151.7A EP3621589B1 (en) | 2017-05-11 | 2018-05-09 | A process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic |
| PCT/EP2018/061955 WO2018206619A1 (en) | 2017-05-11 | 2018-05-09 | A process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3621589T3 true PL3621589T3 (pl) | 2021-12-06 |
Family
ID=58707344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18725151T PL3621589T3 (pl) | 2017-05-11 | 2018-05-09 | Sposób wytwarzania preparatu suchego proszku obejmującego środek antycholinergiczny, kortykosteroid i środek beta-adrenergiczny |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10350164B2 (pl) |
| EP (1) | EP3621589B1 (pl) |
| KR (3) | KR20240105510A (pl) |
| CN (2) | CN110612095A (pl) |
| BR (1) | BR112019023386A2 (pl) |
| CA (1) | CA3059824A1 (pl) |
| ES (1) | ES2882153T3 (pl) |
| MA (1) | MA48620A (pl) |
| MX (1) | MX374484B (pl) |
| PL (1) | PL3621589T3 (pl) |
| RU (1) | RU2741427C1 (pl) |
| WO (1) | WO2018206619A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3060020A1 (en) * | 2017-05-11 | 2018-11-15 | Chiesi Farmaceutici S.P.A. | A process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic |
| EP4034079A1 (en) | 2019-09-24 | 2022-08-03 | Chiesi Farmaceutici S.p.A. | Novel carrier particles for dry powder formulations for inhalation |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1131059T3 (da) * | 1998-11-13 | 2003-06-30 | Jago Res Ag | Tørpulver til inhalation |
| PE20011227A1 (es) | 2000-04-17 | 2002-01-07 | Chiesi Farma Spa | Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros |
| GB0015043D0 (en) | 2000-06-21 | 2000-08-09 | Glaxo Group Ltd | Medicament dispenser |
| PT1386630E (pt) | 2002-07-31 | 2006-09-29 | Chiesi Farma Spa | Inalador em po |
| GB0525254D0 (en) * | 2005-12-12 | 2006-01-18 | Jagotec Ag | Powder compositions for inhalation |
| GB0613161D0 (en) * | 2006-06-30 | 2006-08-09 | Novartis Ag | Organic Compounds |
| JP5914354B2 (ja) * | 2009-12-23 | 2016-05-11 | シエシー ファルマセウティチィ ソシエタ ペル アチオニ | Ｃｏｐｄ用併用療法 |
| EP3409270B1 (en) * | 2013-07-11 | 2021-02-24 | Chiesi Farmaceutici S.p.A. | Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation |
| US9554992B2 (en) * | 2014-06-09 | 2017-01-31 | Chiesi Farmaceutici S.P.A. | Inhalation particles comprising a combination of an anticholinergic, a corticosteroid and a beta-adrenergic |
| TR201910186T4 (tr) | 2014-06-30 | 2019-08-21 | Chiesi Farm Spa | Kuru toz inhalatörü ve bunun inhalasyonla çalıştırılan mekanizması. |
| CN105982880A (zh) * | 2015-03-16 | 2016-10-05 | 四川海思科制药有限公司 | 一种干粉吸入剂药物组合物及其制备方法 |
| PT3689379T (pt) * | 2015-11-16 | 2021-09-24 | Chiesi Farm Spa | Processo para preparar uma formulação de pó seco que compreende um anticolinérgico, um corticoide e um betaadrenérgico |
| SI3377108T1 (sl) * | 2015-11-16 | 2020-05-29 | Chiesi Farmaceutici S.P.A. | Postopek za pripravo suhe praškaste formulacije, ki obsega antiholinergik, kortikosteroid in beta-adrenergik |
-
2018
- 2018-05-09 ES ES18725151T patent/ES2882153T3/es active Active
- 2018-05-09 KR KR1020247021476A patent/KR20240105510A/ko active Pending
- 2018-05-09 CN CN201880029972.XA patent/CN110612095A/zh active Pending
- 2018-05-09 WO PCT/EP2018/061955 patent/WO2018206619A1/en not_active Ceased
- 2018-05-09 BR BR112019023386-5A patent/BR112019023386A2/pt active IP Right Grant
- 2018-05-09 PL PL18725151T patent/PL3621589T3/pl unknown
- 2018-05-09 MA MA048620A patent/MA48620A/fr unknown
- 2018-05-09 KR KR1020227038721A patent/KR20220155609A/ko not_active Ceased
- 2018-05-09 KR KR1020197033080A patent/KR102637298B1/ko active Active
- 2018-05-09 CA CA3059824A patent/CA3059824A1/en active Pending
- 2018-05-09 CN CN202411854831.5A patent/CN119656140A/zh active Pending
- 2018-05-09 MX MX2019012930A patent/MX374484B/es active IP Right Grant
- 2018-05-09 RU RU2019139867A patent/RU2741427C1/ru active
- 2018-05-09 US US15/975,017 patent/US10350164B2/en active Active
- 2018-05-09 EP EP18725151.7A patent/EP3621589B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| MX374484B (es) | 2025-03-04 |
| KR102637298B1 (ko) | 2024-02-20 |
| CA3059824A1 (en) | 2018-11-15 |
| US20180325815A1 (en) | 2018-11-15 |
| EP3621589A1 (en) | 2020-03-18 |
| KR20220155609A (ko) | 2022-11-23 |
| MA48620A (fr) | 2021-04-28 |
| CN119656140A (zh) | 2025-03-21 |
| MX2019012930A (es) | 2020-01-14 |
| KR20240105510A (ko) | 2024-07-05 |
| ES2882153T3 (es) | 2021-12-01 |
| RU2741427C1 (ru) | 2021-01-26 |
| US10350164B2 (en) | 2019-07-16 |
| CN110612095A (zh) | 2019-12-24 |
| EP3621589B1 (en) | 2021-07-07 |
| WO2018206619A1 (en) | 2018-11-15 |
| BR112019023386A2 (pt) | 2020-06-16 |
| KR20190142769A (ko) | 2019-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201803168B (en) | A process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic | |
| ZA201803167B (en) | A process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic | |
| IL243507A0 (en) | A dry powder formulation containing an anticholinergic agent, a steroid and an adrenergic agent for inhalation administration | |
| ZA202004349B (en) | Fluoralkenyl compounds, process for preparation and use thereof | |
| PL3621589T3 (pl) | Sposób wytwarzania preparatu suchego proszku obejmującego środek antycholinergiczny, kortykosteroid i środek beta-adrenergiczny | |
| PL3621590T3 (pl) | Sposób wytwarzania preparatu suchego proszku zawierającego środek antycholinergiczny, kortykosteroid i środek beta-adrenergiczny | |
| HK40117217A (zh) | 制备包含抗胆碱能药、皮质类固醇和β-肾上腺素能药的干粉制剂的方法 | |
| PL3592333T3 (pl) | Kompozycja farmaceutyczna zawierająca racekadotryl i sposób jej otrzymywania | |
| TH1601000099A (th) | สูตรผสมผงแห้งที่ประกอบรวมด้วยแอนติโคลิเนอร์จิก, คอร์ติโคสเตียรอยด์ และเบตา-แอดรีเนอร์จิกสำหรับการให้โดยการสูด | |
| SG10202111096SA (en) | Process for preparing a crassocephalum crepidioides extract, extract prepared thereby and use of the extract |